Inhibiting glycogen synthase kinase-3 (GSK-3) prevents the development of myeloma bone disease

被引：1
|
作者：
Abdul, N. [1 ]
Stoop, W. [2 ]
Koopman, W.
Djerbi, M.
Chantry, A. D. [1 ]
Evans, H. [1 ]
Vanderkerken, K. [2 ]
Croucher, P. I. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Vrije Univ Brussel, Dept Haematol & Immunol, Brussels, Belgium
来源：
BONE | 2009年 / 44卷
关键词：
D O I：
10.1016/j.bone.2009.01.462
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
103
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [1] Glycogen synthase kinase-3 (GSK-3): A kinase with exceptional therapeutic potential
    Benbow, JW
    Helal, CJ
    Kung, DW
    Wager, TT
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 135 - 147
  • [2] Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
    Medina, Miguel
    Avila, Jesus
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (25) : 2790 - 2798
  • [3] Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
    Pandey, Mukesh K.
    DeGrado, Timothy R.
    THERANOSTICS, 2016, 6 (04): : 571 - 593
  • [4] Expression and localization of glycogen synthase kinase-3 (GSK-3) in mouse
    Yao, HB
    Shaw, PC
    Wan, DCC
    FASEB JOURNAL, 2001, 15 (04): : A547 - A547
  • [5] Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
    Medina, Miguel
    Castro, Ana
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 533 - 543
  • [6] Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway
    Pan, Hsuan-Yeh
    Valapala, Mallika
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [7] Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
    Golpich, Mojtaba
    Amini, Elham
    Hemmati, Fatemeh
    Ibrahim, Norlinah Mohamed
    Rahmani, Behrouz
    Mohamed, Zahurin
    Raymond, Azman Ali
    Dargahi, Leila
    Ghasemi, Rasoul
    Ahmadiani, Abolhassan
    PHARMACOLOGICAL RESEARCH, 2015, 97 : 16 - 26
  • [8] Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme
    Atkins, R. J.
    Stylli, S. S.
    Luwor, R. B.
    Kaye, A. H.
    Hovens, C. M.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (09) : 1185 - 1192
  • [9] A Noncatalytic Domain of Glycogen Synthase Kinase-3 (GSK-3) Is Essential for Activity
    Buescher, Jessica L.
    Phiel, Christopher J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) : 7957 - 7963
  • [10] A Novel Potent and Selective Inhibitor of Glycogen Synthase Kinase-3 (GSK-3)
    Noori, Mahboubeh S.
    Courreges, Maria C.
    Bergmeier, Stephen C.
    McCall, Kelly D.
    Goetz, Douglas J.
    FASEB JOURNAL, 2018, 32 (01):
12345